Mark E. Schnute
Pfizer (United States)(US)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Organic Chemistry Cycloaddition Reactions, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, Oxidative Organic Chemistry Reactions
Most-Cited Works
- → A road map to evaluate the proteome-wide selectivity of covalent kinase inhibitors(2014)359 cited
- → Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1(2012)275 cited
- → A Novel Autotaxin Inhibitor Reduces Lysophosphatidic Acid Levels in Plasma and the Site of Inflammation(2010)228 cited
- → The First Formal Asymmetric Synthesis of Phorbol(1997)196 cited
- → Chemistry of Enoxysilacyclobutanes: Highly Selective Uncatalyzed Aldol Additions(1994)154 cited
- → Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis(2013)108 cited
- → Gas-phase acidities of carboxylic acids and alcohols from collision-induced dissociation of dimer cluster ions(1990)88 cited
- → Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes(2010)69 cited
- → Nitroalkene Inter [4 + 2]/Intra [3 + 2] Tandem Cycloadditions. 7. Application of (R)-(-)-2,2-Diphenylcyclopentanol as the Chiral Auxiliary(1995)63 cited
- → Tandem inter [4+2]/intra [3+2]nitroalkene cycloadditions. 5. Origin of the Lewis acid dependent reversal of stereoselectivity(1993)63 cited